Literature DB >> 7718086

Physiological enzymatic cleavage of leukocyte membrane molecules.

V Bazil1.   

Abstract

Certain membrane molecules are enzymatically cleaved from the cell surface and then released into the extracellular medium in the form of soluble fragments. This process, commonly initiated by cell stimulation, may regulate the surface expression of such molecules, and may also be responsible for the production of their soluble forms in vivo. Here, Vladimír Bazil provides an overview of the molecules that are cleaved from cells, focusing particularly on leukocyte receptors. In addition, he discusses the mechanisms and putative enzymes involved in this process, as well as the potential physiological significance of such events.

Mesh:

Substances:

Year:  1995        PMID: 7718086     DOI: 10.1016/0167-5699(95)80130-8

Source DB:  PubMed          Journal:  Immunol Today        ISSN: 0167-5699


  18 in total

1.  Insulin-regulated increase of soluble vascular adhesion protein-1 in diabetes.

Authors:  Marko Salmi; Craig Stolen; Pekka Jousilahti; Gennady G Yegutkin; Päivi Tapanainen; Tuula Janatuinen; Mikael Knip; Sirpa Jalkanen; Veikko Salomaa
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

2.  Release of membrane-associated L-dopa decarboxylase from human cells.

Authors:  Ioanna Chalatsa; Emmanuel G Fragoulis; Dido Vassilacopoulou
Journal:  Neurochem Res       Date:  2011-04-11       Impact factor: 3.996

3.  Selective killing of human monocytes and cytokine release provoked by sphingomyelinase (beta-toxin) of Staphylococcus aureus.

Authors:  I Walev; U Weller; S Strauch; T Foster; S Bhakdi
Journal:  Infect Immun       Date:  1996-08       Impact factor: 3.441

4.  Pore-forming toxins trigger shedding of receptors for interleukin 6 and lipopolysaccharide.

Authors:  I Walev; P Vollmer; M Palmer; S Bhakdi; S Rose-John
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-23       Impact factor: 11.205

5.  Secretion imbalance between tumour necrosis factor and its inhibitor in inflammatory bowel disease.

Authors:  M Noguchi; N Hiwatashi; Z Liu; T Toyota
Journal:  Gut       Date:  1998-08       Impact factor: 23.059

6.  Immune complexes (IC) down-regulate the basal and interferon-gamma-induced expression of MHC class II on human monocytes.

Authors:  P Barrionuevo; M Beigier-Bompadre; S De La Barrera; M F Alves-Rosa; G Fernandez; M S Palermo; M A Isturiz
Journal:  Clin Exp Immunol       Date:  2001-08       Impact factor: 4.330

7.  Detection of a soluble form of the leukocyte surface antigen CD48 in plasma and its elevation in patients with lymphoid leukemias and arthritis.

Authors:  G M Smith; J Biggs; B Norris; P Anderson-Stewart; R Ward
Journal:  J Clin Immunol       Date:  1997-11       Impact factor: 8.317

8.  Novel pathogenic mechanism of microbial metalloproteinases: liberation of membrane-anchored molecules in biologically active form exemplified by studies with the human interleukin-6 receptor.

Authors:  P Vollmer; I Walev; S Rose-John; S Bhakdi
Journal:  Infect Immun       Date:  1996-09       Impact factor: 3.441

9.  Human vascular adhesion proteın-1 (VAP-1): serum levels for hepatocellular carcinoma in non-alcoholic and alcoholic fatty liver disease.

Authors:  Ozgur Kemik; Aziz Sümer; Ahu Sarbay Kemik; Veyis Itik; Ahmet Cumhur Dulger; Sevim Purisa; Sefa Tuzun
Journal:  World J Surg Oncol       Date:  2010-09-17       Impact factor: 2.754

10.  Induction of Heymann nephritis with a gp330/megalin fusion protein.

Authors:  R Raychowdhury; G Zheng; D Brown; R T McCluskey
Journal:  Am J Pathol       Date:  1996-05       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.